Moffitt Notice of Blackbaud Data Incident. Learn More
Clinical Trials Search
Clinical Trial 20415
Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT04182204
Phase: Phase III
Prinicipal Investigator: Jose Sandoval-Sus
Study Title
A Phase III, Open-Label, Multicenter, Randomized Study Evaluating The Saftey And Efficacy Of Polatuzumab Vedotin In Combination With RituximabI Plus Gemcitabine Plus Oxaliplatin (R-Gemox) Versus R-Gemox Alone In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Summary
Objective
Therapies
Medications
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
